Standard versus rapid-deployment aortic valve replacement and concomitant myocardial revascularization: 5-year bi-centre clinical outcomes.
Tomaso Bottio Jean Christian RousselAntonio PiperataAlvise GuarientoGiulia LorenzoniAndrea Gualtiero CavicchioloMarco GemelliRita PesceGiuseppe EvangelistaSara MichelottiElisa GastinoDario GregoriEnrico FerrariGino GerosaPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2022)
RD and ME pericardial bioprostheses used in concomitant aortic valve replacement and coronary artery revascularization provide equivalent clinical and haemodynamic 5-year outcomes, despite constant lower transvalvular gradients and shorter surgical operating times observed with RD technology.
Keyphrases
- aortic valve replacement
- coronary artery
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve
- coronary artery bypass grafting
- percutaneous coronary intervention
- left ventricular
- pulmonary artery
- transcatheter aortic valve replacement
- ejection fraction
- coronary artery disease
- acute coronary syndrome
- type diabetes
- metabolic syndrome
- atrial fibrillation
- skeletal muscle
- adipose tissue
- weight loss
- insulin resistance
- glycemic control
- sensitive detection